Railway Pension Investments Ltd Buys 2,300 Shares of HCA Healthcare, Inc. $HCA

Railway Pension Investments Ltd raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 106,767 shares of the company’s stock after purchasing an additional 2,300 shares during the quarter. Railway Pension Investments Ltd’s holdings in HCA Healthcare were worth $40,902,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of HCA. Park Place Capital Corp raised its holdings in HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after acquiring an additional 2,698 shares during the period. Swiss National Bank increased its position in HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after acquiring an additional 23,100 shares during the period. Cherokee Insurance Co acquired a new position in HCA Healthcare during the second quarter valued at approximately $3,869,000. Finally, Harrell Investment Partners LLC grew its position in HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after acquiring an additional 1,158 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

HCA has been the topic of several research reports. Wells Fargo & Company boosted their price target on HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a report on Thursday, November 13th. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, October 27th. TD Cowen increased their price objective on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday, October 27th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a research report on Monday, October 27th. Finally, Truist Financial lifted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Price Performance

NYSE HCA opened at $512.94 on Friday. The stock has a market capitalization of $117.05 billion, a P/E ratio of 19.83, a P/E/G ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00. The business has a 50 day simple moving average of $452.07 and a 200 day simple moving average of $406.38.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter last year, the firm posted $4.90 EPS. The company’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.